Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 22, 2025, Revance Therapeutics (RVNC) has a market cap of $0.38 billion USD. According to our data, Revance Therapeutics is ranked No.6280 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 22, 2025 | $0.38 B |
20.07%
|
| Dec 31, 2024 | $0.32 B |
-65.42%
|
| Dec 29, 2023 | $0.92 B |
-52.38%
|
| Dec 30, 2022 | $1.93 B |
13.11%
|
| Dec 31, 2021 | $1.70 B |
-42.41%
|
| Dec 31, 2020 | $2.96 B |
74.61%
|
| Dec 31, 2019 | $1.69 B |
-19.37%
|
| Dec 31, 2018 | $2.10 B |
-43.69%
|
| Dec 29, 2017 | $3.73 B |
72.71%
|
| Dec 30, 2016 | $2.16 B |
-39.40%
|
| Dec 31, 2015 | $3.57 B |
101.65%
|
| Dec 31, 2014 | $1.77 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Evolus
EOLS
|
$0.69 B |
26.259 M
|
USA
|
 AbbVie
ABBV
|
$313.37 B |
5.126 B
|
USA
|
 Pfizer
PFE
|
$127.67 B |
0.577 B
|
USA
|
 Johnson & Johnson
JNJ
|
$379.31 B |
1.324 B
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$16.28 B |
0.387 B
|
Israel
|
 Sanofi
SNY
|
$128.06 B |
1.869 B
|
France
|
 GlaxoSmithKline
GSK
|
$74.47 B |
-0.004 M
|
UK
|
 Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
USA
|
| Market Cap | = | RVNC Stock Price | * | RVNC Shares Outstanding |
| = | $3.65 | * | 0.10 B | |
| = | $0.38 B |